Supporters of the bill said heavy lobbying by pharmaceutical and biotechnology companies, universities and trial lawyers prevented the law from advancing.
via NYT > Business Day http://ift.tt/1tmabwv
via WordPress http://ift.tt/1gR8zcc
via All Business Is Good Business http://ift.tt/1kqzDy0
via WordPress http://ift.tt/Rb3leY
0 comments:
Post a Comment